To understand the implications of altered iron metabolism, we assessed the expression of the following three major regulators of iron metabolism and their relationship with NSCLC clinical outcomes: transferrin receptor (TfR; TFRC), ferritin heavy chain (FtH; FTH1), and ferroportin (Fpn-1; SLC40A1). Here, SLC40A1 is linked to non-small cell lung carcinoma.